Anatomical Pathology Special Stains and Immunohistochemistry
RCPAQAP myQAP login Data Analysis

Calretinin

Platform
Leica Bond III
Clone/manufacturer
NCL-Calretinin (5A5)
Antibody dilution
1:20
Antibody incubation time/temp
30
Antigen retrieval buffer time/temp
Leica Visionbiosystems ER1 for 30 mins
Amplification
Not applicable
Detection kit
DS9713 DAB Polymer Refine
Program (mark)
General 2011 (4.2/5)

Calretinin is a 29 kDa calcium‑binding protein that shows combined nuclear and cytoplasmic staining on IHC and is used primarily to support mesothelial or sex‑cord stromal lineage. It is strongly positive in pleural and peritoneal mesotheliomas while negative in lung adenocarcinomas, making it a key component of mesothelioma diagnostic IHC panels. Calretinin also assists in evaluating Hirschsprung disease by highlighting normal mucosal innervation, and helps distinguish adrenal cortical lesions (positive) from pheochromocytoma (negative). Additional uses include confirming sex‑cord stromal tumours and contributing to panels for mesonephric carcinoma and STK11‑associated adnexal tumours (1).

Recommended Controls

Criteria for acceptable staining is strong cytoplasmic and nuclear staining. Appendix will demonstrate both negative (columnar epithelial cells and smooth muscle cells) and strong distinct positive cytoplasmic and nuclear staining (peripheral nerves, ganglions, axons and macrophages).

Expected staining pattern


Appendix ganglion cells


Mesothelioma

Disclaimer

These methods are intended as a guide only. Laboratories that wish to implement these methods should perform internal validation/verification prior to use. The RCPAQAP does not make any claim or warranty for the accuracy or performance of these methods.

References
  1. Baniak N. Calretinin. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/stainscalretinin.html.

  2. Images of appendix ganglion cells and mesothelioma_QAP survey results

Last updated on March 05, 2026
Back to top
en_AUEnglish
It appears you're using an old version of Internet Explorer for safer and optimum browsing experience please upgrade your browser.